Publication Details

Pubmed29876933
Title: Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
Year: 2018
DOI: https://doi.org/10.1002/path.5108
First Author: Liu
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
HDAC6_HUMANRD23B_HUMANBioGRIDdetails